Media Pack
News

Current Edition

Volume 16 Issue 1
 
Volume 15 Issue 4

Enhancing the Data Journey in Oncology Clinical Trials

Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation of new treatments and next-generation therapies for pat...
24 January 2024 Volume 15 Issue 4 clinical | data
Continue Reading →
Volume 15 Issue 2

Clinical Trial Technology Trends: The Top 5 Innovations Shaping Clinical Trials in 2023

Clinical trials play a crucial role in the development and approval of new medical treatments and drugs. As technology continues to advance, Clinical Trial Technolog...
6 July 2023 Volume 15 Issue 2 approval | clinical
Continue Reading →
Volume 15 Issue 2

WhyzeHealth:

Improving Access and Participation in Clinical Trials in Ireland, a Patient-centred Digital Health Platform Across Europe, we continue to see a declining trend in...
6 July 2023 Volume 15 Issue 2 clinical | COVID-19
Continue Reading →
Volume 15 Issue 2

Ensuring Unbiased Oversight: The Case for Independent Expert Committee Management

Expert committees are a critical component in the success of a clinical trial. By turning to third-party providers to manage these services, sponsors can enhance tri...
6 July 2023 Volume 15 Issue 2 case | clinical
Continue Reading →
Volume 15 Issue 2

Exploring the Limb Girdle Muscular Dystrophy Clinical Trial Landscape

With the recent advent of adeno-associated, virus-based gene therapy treatments, limb-girdle muscular dystrophy (LGMD) is currently attracting the attention of the b...
6 July 2023 Volume 15 Issue 2 adeno-associated | clinical
Continue Reading →
Volume 15 Issue 2

Shipping Clinical Trials, Robustly and Reliably

According to recent forecasts by Fortune Business Insights, the global clinical trials market is projected to reach nearly $100 billion in 2030. That represents huge...
6 July 2023 Volume 15 Issue 2 clinical | forecasts
Continue Reading →
Volume 14 Issue 6

Recent FDA Advancements in Rare Diseases – Funding, Partnerships, and Programs

The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical products or...
30 November 2022 Volume 14 Issue 6 applications | approved
Continue Reading →
Volume 14 Issue 6

Impact of Electronic Signature Towards Clinical Trial Agreements

The use of electronic signatures is desirable for companies nowadays as technology has growingly become an integral part of our life. Not only that, implementing it c...
30 November 2022 Volume 14 Issue 6 Agreements | clinical
Continue Reading →
Volume 14 Issue 6

Improving Clinical Study Publishing Success

Academic publishing is highly competitive, and this competition is only growing as more and more research papers are being submitted to top journals – submissions to ...
30 November 2022 Volume 14 Issue 6 clinical | competitive
Continue Reading →
Regional News

Biogen piles on more long-term Aduhelm data, linking biomarker to Alzheimer’s clinical benefit

Despite a disastrous commercial rollout, Biogen is still producing longer-term data for beleaguered Alzheimer’s disease therapy Aduhelm. In patients who’ve been t...
17 March 2022 Regional News Aduhelm | Alzheimer
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte